AbCellera
is the most potent antibody in development against the omicron variant | AbCellera
Company
Deck Type
Sector
Industry
Deck date
February 2022
Slide
12 of 21
Related slides by other companies
Adagio Therapeutics
IPO
August 2021
identification and optimization of broad and potent neutralizing antibodies against at an ave | Adagio Therapeutics
Erasca
IPO
July 2021
we believe eras is the most potent inhibitor in development | Erasca
Other recent decks by AbCellera
See all presentations (23 decks)
Investor Presentation
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights